Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +918265041513 (International callers) or +918265041513 (Indian callers).
Antibiotics — Philippines, South Africa, Australia & Singapore | Azithral · Augmentin · Cifran · Dox
6a6c3e5455202a6960e18c03"
Antibiotics — Philippines, South Africa, Australia & Singapore
(2026)
Product Names
Azithral (Azithromycin)
Augmentin (Amoxicillin + Clavulanic Acid)
Cifran (Ciprofloxacin)
Doxycap (Doxycycline)
Product Details
These antibiotics are prescription medicines used to treat a wide variety of bacterial infections affecting the respiratory tract, skin and soft tissue, urinary tract, gastrointestinal tract, dental infections, sexually transmitted infections, and anaerobic bacterial infections.
They work by either killing bacteria or preventing bacterial growth and should only be used under the guidance of a qualified healthcare professional.
Product Specifications
Product
Active Ingredient
Strengths
Dosage Form
Therapeutic Class
Azithral
Azithromycin
250 mg, 500 mg
Tablets
Macrolide Antibiotic
Augmentin
Amoxicillin + Clavulanic Acid
Various strengths
Tablets, Suspension
Penicillin Antibiotic
Cifran
Ciprofloxacin
250 mg, 500 mg, 750 mg
Tablets
Fluoroquinolone
Doxycap
Doxycycline
100 mg
Capsules
Tetracycline Antibiotic
Key Features
Effective against a broad range of bacterial infections.
Available in tablets, capsules, suspensions, and injectable formulations (product dependent).
Manufactured in WHO-GMP compliant pharmaceutical facilities.
Suitable for hospitals, clinics, pharmacies, wholesalers, and international distributors.
High-quality generic formulations with reliable therapeutic efficacy.
Widely prescribed for respiratory, urinary, skin, dental, gynecological, and gastrointestinal infections.
Available in export-quality packaging for international pharmaceutical markets.
Stable shelf life with proper storage conditions.
Competitive pricing for wholesale and bulk procurement.
Intended for prescription use under medical supervision.
Industry Update
The antibiotic market across Philippines, South Africa, Australia, and Singapore continues to evolve with a strong emphasis on antimicrobial stewardship, responsible prescribing, and surveillance of antimicrobial resistance (AMR). Healthcare authorities are encouraging evidence-based antibiotic use to preserve the effectiveness of existing treatments.
Key industry developments include:
Rising demand for quality generic antibiotics in both hospital and community healthcare settings.
Greater investment in antimicrobial stewardship programs to reduce inappropriate antibiotic prescribing.
Continued monitoring of antibiotic resistance patterns to guide treatment recommendations.
Increased adoption of rapid diagnostic technologies that help clinicians select the most appropriate antibiotic therapy.
Expansion of pharmaceutical distribution networks supporting reliable access to essential anti-infective medicines across Asia-Pacific and Africa.
Australia's latest national surveillance report highlights that while overall antibiotic use remains below levels seen a decade ago, antibiotic prescriptions increased in 2024 and reports of critical antimicrobial resistance also rose, reinforcing the importance of appropriate prescribing and infection prevention.
With the adoption of the WHO Global Action Plan on Antimicrobial Resistance (2026–2036), countries including the Philippines, Australia, Singapore, and South Africa are expected to continue strengthening surveillance systems, antimicrobial stewardship, and access to quality-assured antibiotics while promoting responsible antibiotic use in both healthcare and community settings.
Chat with us
Chat with us
